Abhishek Gupta Selected Research

Phosphoric Monoester Hydrolases (Phosphatases)

9/2023	Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody.
1/2019	PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
1/2016	PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
11/2015	PRL-3 activates mTORC1 in Cancer Progression.
10/2014	A role of autophagy in PTP4A3-driven cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abhishek Gupta Research Topics

Disease

19	Neoplasms (Cancer) 02/2024 - 10/2014
17	Insulin Resistance 01/2023 - 12/2010
13	Obesity 01/2023 - 01/2012
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 12/2010
7	Inflammation (Inflammations) 04/2021 - 01/2013
6	Wounds and Injuries (Trauma) 03/2023 - 12/2016
5	Pain (Aches) 12/2023 - 10/2013
5	COVID-19 07/2023 - 04/2020
5	Body Weight (Weight, Body) 12/2020 - 12/2010
4	Infections 07/2023 - 06/2020
4	Squamous Cell Carcinoma of Head and Neck 01/2020 - 11/2015
3	Postoperative Pain 12/2023 - 01/2022
3	Vomiting 12/2023 - 01/2022
3	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 01/2022
3	Nausea 12/2023 - 01/2022
3	Edema (Dropsy) 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2014
3	Hypertension (High Blood Pressure) 01/2021 - 01/2012
3	Hyperinsulinism (Hyperinsulinemia) 12/2018 - 12/2016
2	Substance-Related Disorders (Drug Abuse) 03/2024 - 08/2021
2	Fibrosis (Cirrhosis) 10/2023 - 01/2019
2	Burns 03/2023 - 05/2021
2	Necrosis 10/2020 - 01/2012
2	Rheumatoid Arthritis 01/2019 - 01/2019
2	Arthritis (Polyarthritis) 01/2019 - 01/2019
2	Hypertrophy 03/2018 - 10/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2017
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2015 - 04/2015
2	Skin Neoplasms (Skin Cancer) 01/2008 - 01/2004
1	Dry Eye Syndromes (Dry Eye Syndrome) 05/2024
1	Meibomian Gland Dysfunction 05/2024
1	Schizophrenia (Dementia Praecox) 03/2024
1	Psychotic Disorders (Schizoaffective Disorder) 03/2024
1	Tobacco Use Disorder (Nicotine Dependence) 03/2024
1	Mental Disorders (Mental Disorder) 03/2024
1	Communicable Diseases (Infectious Diseases) 02/2024
1	Heart Diseases (Heart Disease) 02/2024
1	Immune System Diseases (Immune Disorders) 02/2024
1	Limbal Stem Cell Deficiency 02/2024
1	Periodontal Pocket (Periodontal Pockets) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2023
1	Ascites 10/2023

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 12/2010
10	Insulin (Novolin)FDA Link 06/2023 - 12/2010
6	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2013
5	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2023 - 10/2014
5	CelluloseIBA 03/2023 - 12/2016
5	CytokinesIBA 01/2020 - 01/2012
5	LeptinIBA 01/2018 - 12/2010
5	CholesterolIBA 01/2018 - 12/2010
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2020
4	AdiponectinIBA 10/2018 - 01/2013
4	Triglycerides (Triacylglycerol)IBA 01/2018 - 12/2010
4	LipidsIBA 10/2015 - 12/2010
3	Opioid Analgesics (Opioids)IBA 12/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 04/2023 - 11/2013
3	CollagenIBA 03/2023 - 01/2019
3	Peptides (Polypeptides)IBA 01/2022 - 01/2019
3	HydrogelsIBA 05/2021 - 12/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2015
3	Adenosine Triphosphate (ATP)IBA 08/2012 - 12/2010
2	SteroidsIBA 06/2023 - 01/2023
2	Biopolymers (Biopolymer)IBA 03/2023 - 05/2021
2	ChitosanIBA 03/2023 - 10/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 04/2004
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2023 - 01/2022
2	CyclodextrinsIBA 12/2022 - 11/2020
2	Oncogene Proteins (Oncogene Protein)IBA 11/2021 - 01/2019
2	SolutionsIBA 10/2021 - 04/2020
2	SilverIBA 11/2020 - 12/2016
2	CurcuminIBA 11/2020 - 01/2017
2	AcidsIBA 10/2020 - 05/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
2	PolymersIBA 01/2020 - 10/2018
2	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2013
2	HLA-G Antigens (HLA G)IBA 01/2020 - 02/2017
2	MineralsIBA 01/2019 - 01/2019
2	AntigensIBA 01/2019 - 01/2016
2	ResistinIBA 07/2015 - 08/2012
2	EnzymesIBA 01/2015 - 12/2010
2	Complement System Proteins (Complement)IBA 01/2014 - 01/2013
2	HDL CholesterolIBA 08/2012 - 12/2010
1	Vitamin D FDA LinkGeneric 05/2024
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2024
1	guduchiIBA 02/2024
1	PolyestersIBA 12/2023
1	Morphine (MS Contin)FDA LinkGeneric 12/2023
1	Oxycodone (Oxycontin)FDA LinkGeneric 12/2023
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2023
1	Vascular Endothelial Growth Factor CIBA 10/2023

Therapy/Procedure

16	Therapeutics 10/2023 - 01/2004
5	Immunotherapy 11/2021 - 01/2016
3	Transplantation 02/2024 - 07/2019
2	Injections 03/2022 - 07/2020
2	Lasers (Laser) 01/2022 - 01/2022
2	Sclerotherapy 01/2022 - 01/2022
2	Semiconductor Lasers 01/2022 - 01/2022
2	Condoms (Condom) 10/2015 - 04/2015
2	Chemoprevention 01/2008 - 01/2004